Correspondence 0001493152-24-016921 from Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE)

Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: April 29, 2024 · CIK: 0001401914 · Accession: 0001493152-24-016921

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-278378

Date

March 29, 2024

Author

DARÉ

Form

CORRESP

Company

Dare Bioscience, Inc. (DARE) (CIK 0001401914)

Letter

Daré Bioscience, Inc.

Nobel Drive, Suite 260

San Diego, CA 92122

April 29, 2024

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

Re: Daré Bioscience, Inc.

Registration Statement on Form S-3

Filed March 29, 2024

File No. 333-278378

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Daré Bioscience, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above (the “Registration Statement”) be accelerated so that it becomes effective at 4:00 p.m., Eastern Time, on May 1, 2024, or as soon thereafter as possible.

Please notify Edwin Astudillo of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (619) 318-9987 when the Registration Statement has been declared effective pursuant to this request and/or contact him with any questions.

Sincerely,
DARÉ
BIOSCIENCE, INC.

Show Raw Text

CORRESP
1
filename1.htm

Daré
Bioscience, Inc.

3655
Nobel Drive, Suite 260

San
Diego, CA 92122

April
29, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Daniel Crawford

 Re: Daré
                                            Bioscience, Inc.

                                            Registration Statement on Form S-3

                                            Filed March 29, 2024

                                            File No. 333-278378

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Daré Bioscience, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above (the “Registration Statement”)
be accelerated so that it becomes effective at 4:00 p.m., Eastern Time, on May 1, 2024, or as soon thereafter as possible.

Please
notify Edwin Astudillo of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (619) 318-9987 when the Registration
Statement has been declared effective pursuant to this request and/or contact him with any questions.

    Sincerely,

    DARÉ
    BIOSCIENCE, INC.

    By:
    /s/
    Sabrina Martucci Johnson

    Name:
    Sabrina
    Martucci Johnson

    Title:
    Chief
    Executive Officer

SecProbe.io